Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
A 44-year-old-female with angioid streak- (AS-) associated choroidal-neovascularization (CNV) was treated with one dose of intravitreal brolucizumab (IB). At one-month, the patient’s visual acuity (VA) improved from 20/120 to 20/40 with a dry macula on spectral-domain optical-coherence tomography (S...
Saved in:
Main Authors: | Somnath Chakraborty, Jay Umed Sheth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/3442306 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
by: Sónia Torres-Costa, et al.
Published: (2022-01-01) -
Comprehensive review of angioid streaks
by: Sindhuja Kandasamy, et al.
Published: (2025-01-01) -
Angioid streaks. A case report
by: Aimé Broche Hernández, et al.
Published: (2011-03-01) -
Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab
by: Settimio Rossi, et al.
Published: (2025-01-01) -
The initial results of using brolucizumab (Beovu®), an angiogenesis inhibitor, for choroidal neovascularization in patients with age-related macular degeneration
by: N.S. Zhayvoronok, et al.
Published: (2022-11-01)